PT951481E - Utilizacao de substancias com accao imunomoduladora para o tratamento da esclerose lateral amiotrofica - Google Patents

Utilizacao de substancias com accao imunomoduladora para o tratamento da esclerose lateral amiotrofica

Info

Publication number
PT951481E
PT951481E PT97951843T PT97951843T PT951481E PT 951481 E PT951481 E PT 951481E PT 97951843 T PT97951843 T PT 97951843T PT 97951843 T PT97951843 T PT 97951843T PT 951481 E PT951481 E PT 951481E
Authority
PT
Portugal
Prior art keywords
receptors
immunoglobulins
gamma
bind
lateral sclerosis
Prior art date
Application number
PT97951843T
Other languages
English (en)
Inventor
Walter Dr Schubert
Original Assignee
Mpb Meltec Patent Und Beteilig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19723690A external-priority patent/DE19723690A1/de
Application filed by Mpb Meltec Patent Und Beteilig filed Critical Mpb Meltec Patent Und Beteilig
Publication of PT951481E publication Critical patent/PT951481E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PT97951843T 1997-06-05 1997-12-10 Utilizacao de substancias com accao imunomoduladora para o tratamento da esclerose lateral amiotrofica PT951481E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19723690A DE19723690A1 (de) 1996-06-05 1997-06-05 Verwendung von Substanzen mit immunmodulatorischer Wirkung für die Behandlung der amyotrophen Lateralsklerose
PCT/DE1997/002883 WO1999029731A1 (de) 1997-06-05 1997-12-10 Verwendung von substanzen mit immunmodulatorischer wirkung für die behandlung der amyotrophen lateralsklerose

Publications (1)

Publication Number Publication Date
PT951481E true PT951481E (pt) 2005-04-29

Family

ID=25962943

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97951843T PT951481E (pt) 1997-06-05 1997-12-10 Utilizacao de substancias com accao imunomoduladora para o tratamento da esclerose lateral amiotrofica

Country Status (7)

Country Link
EP (1) EP0951481B1 (pt)
JP (1) JP2001511821A (pt)
AT (1) ATE283290T1 (pt)
DK (1) DK0951481T3 (pt)
ES (1) ES2234038T3 (pt)
PT (1) PT951481E (pt)
WO (1) WO1999029731A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211602B2 (en) 2001-11-16 2007-05-01 Als Therapy Development Foundation, Inc. Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
WO2013055865A1 (en) 2011-10-11 2013-04-18 The Brigham And Women's Hospital, Inc. Micrornas in neurodegenerative disorders
DE102016103562A1 (de) * 2015-09-17 2017-03-23 Topos Nomos Ltd. Pharmazeutische Wirkstoffe zur Verwendung in der Behandlung von Amyotropher Lateralsklerose (ALS) und Diagnoseverfahren
DE102016106510A1 (de) * 2016-04-08 2017-10-12 ToposNomos Ltd. Verfahren und Vorrichtung zum extrakorporalen Entfernen von pathogenen und/oder überzähligen Bestandteilen aus einer Zellprobe eines Patienten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655269B1 (fr) * 1989-12-01 1994-02-11 Curie Universite Pierre Marie Proteines empechant l'interaction entre un fragment fc d'une immunoglobuline et son recepteur et utilisation en therapeutique, notamment dans le traitement des affections liees aux virus hiv.
FR2702481B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux récepteurs Fc-gamma III humains solubles, leur procédé de préparation, les compositions pharmaceutiques les contenant, leur application comme médicaments et leur application diagnostique.
DE19723690A1 (de) * 1996-06-05 1998-03-26 Schubert Walter Dr Md Verwendung von Substanzen mit immunmodulatorischer Wirkung für die Behandlung der amyotrophen Lateralsklerose

Also Published As

Publication number Publication date
EP0951481B1 (de) 2004-11-24
ATE283290T1 (de) 2004-12-15
WO1999029731A1 (de) 1999-06-17
DK0951481T3 (da) 2005-03-21
ES2234038T3 (es) 2005-06-16
EP0951481A1 (de) 1999-10-27
JP2001511821A (ja) 2001-08-14

Similar Documents

Publication Publication Date Title
RU2220980C2 (ru) Химерное антитело, которое связывается с cd40 человека (варианты), молекула нуклеиновой кислоты (варианты), вектор экспрессии (варианты), гуманизированное антитело (варианты), фармацевтическая композиция для лечения заболевания, опосредованного т-клетками (варианты), способ лечения больного от заболевания, опосредованного т-клетками (варианты)
US4676980A (en) Target specific cross-linked heteroantibodies
Ghetie et al. Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
Billiau Gamma-interferon: the match that lights the fire?
Lubeck et al. The interaction of murine IgG subclass proteins with human monocyte Fc receptors.
RU2432364C2 (ru) ПОЛИКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВ Nogo, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЕ АНТИТЕЛА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА
ATE454124T1 (de) Rekombinante anti-cd30-antikörper und deren verwendungen
YU34196A (sh) Peptidi i jedinjenja koja se vezuju za receptor
SG165161A1 (en) Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
DE69942671D1 (de) Humanisierte antikoerper gegen gamma-interferon
KR960704576A (ko) CD40에 대한 항체(Antibodies to CD40)
DE60032486D1 (de) Prion protein peptide und deren verwendung
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
Frey et al. Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3-large granular lymphocytes.
DK1331944T3 (da) Anvendelse af CD28-specifikke monoklonale antistoffer til stimulering af blodlegemer, der ikke bærer CD28
KR930701192A (ko) 다가의 항-시토킨 면역글로블린
AU6819600A (en) Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
ATE235551T1 (de) Ligand (tie ligand-4) vom tie-2 rezeptor und dessen verwendungen
PT951481E (pt) Utilizacao de substancias com accao imunomoduladora para o tratamento da esclerose lateral amiotrofica
CN1056084C (zh) 抗与表面抗原相关的cd33的免疫毒素
DE69630682D1 (de) Synthetische peptide und diese enthaltende arzneimittel zur behandlung des systemischen lupus erythematodes
Schneiderman et al. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.
WO2004100882A3 (en) Inhibition of drug binding to serum albumin
Fernandes et al. Neutralization of bothropic and crotalic venom toxic activities by IgG (T) and IgGa subclasses isolated from immune horse serum
Suzuki et al. Solubilization of immune complex deposits by native 7S IgG molecules in lupus glomerulonephritis--a possible antigen excess effect on rheumatoid factor-IgG complexes.